WuXi PharmaTech Statement on Recent News Report

SHANGHAI, January 5, 2015 /PRNewswire/ — WuXi PharmaTech stated today that a recent news report regarding purported FDA communication with a company named Novacyl Wuxi Pharmaceutical does not relate to WuXi PharmaTech.

Ron Aldridge
Director of Investor Relations
WuXi PharmaTech
+1 201-585-2048
+1 952-594-0148 (U.S.)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wuxi-pharmatech-statement-on-recent-news-report-300015312.html

Leave a Reply